Oct. 15 SessionRegistration opens Oct. 1
The selected study presents important data about SARS-CoV-2 sequence diversity in infected individuals and provides evidence that a single-dose vaccine may be efficacious against the virus. Our presenter and panelists, with their diverse expertise, will lead an in-depth discussion of the findings and explore the evolution of SARS-CoV-2 over time by analyzing sequence diversity across 5,700 sequences sampled since December 2019. Based on the findings of the paper, the panelists will touch on some aspects of vaccine development efforts, as many of the vaccine candidates are in clinical trials.
A SARS-CoV-2 vaccine candidate would likely match all currently circulating variants
Authors: Bethany Dearlove, Eric Lewitus, Hongjun Bai, Yifan Li, Daniel B. Reeves, M. Gordon Joyce, Paul T. Scott, Mihret F. Amare, Sandhya Vasan, Nelson L. Michael, Kayvon Modjarrad, Morgane Rolland
Proceedings of the National Academy of Sciences Sep 2020, 117 (38) 23652-23662;
Copyright © 2020 the Author(s). Published by PNAS.
This open access article is distributed under Creative Commons Attribution License 4.0 (CC BY).
John J. Dennehy, Ph.D.
The City University of New York
Vaughn Cooper, Ph.D.
University of Pittsburgh
Nov. 19, 2020, 2 p.m. EDT (registration will open Nov. 1)
Missed a past session?
Recordings are available free to ASM members.